Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Royal Society Open Science|May 7, 2016
Tracking urban activity growth globally with big location dataMatthew L Daggitt, Anastasios Noulas, Blake Shaw, et al.
Headache|July 7, 2025
A retrospective cohort study to evaluate the effectiveness and safety profile of occipital nerve blocks in the treatment of migraine during pregnancyLiza Smirnoff, Leon Moskatel, Blake Shaw, et al.
The American Surgeon|May 8, 2026
Contrast Induced Nephropathy in Trauma: A Real Phenomenon?Richard H Lewis, Braden McIntosh, Shahrzad Talebinejad, et al.
Igie : Innovation, Investigation and Insights|February 6, 2026
Exploring human-artificial intelligence interactions in a negative pragmatic trial of computer-aided polyp detectionKate Watkins, Uri Ladabaum, Esther Olsen, et al.
Open Forum Infectious Diseases|October 30, 2025
Longitudinal Patient-Reported Outcome Trajectories in Long COVID: Findings From the STOP-PASC Clinical TrialPrasanna Jagannathan, Haley Hedlin, Jane W Liang, et al.
Journal of Diabetes Science and Technology|December 23, 2024
Addressing Disparities Using Continuous Glucose Monitors and Remote Patient Monitoring for Youth With Type 1 DiabetesMing Yeh Lee, Victor Ritter, Blake Shaw, et al.
The Journal of Pediatrics|May 26, 2026
Mitigating Glycemic Disparities: Understanding Contributions of Sociodemographic Variables in the 4T StudyAnanta Addala, Victor Ritter, Blake Shaw, et al.
Contemporary Clinical Trials|May 25, 2026
Micro-randomization trial design under operational constraintsBryan Bunning, Victor Ritter, Franziska K Bishop, et al.
Diabetes, Obesity & Metabolism|November 28, 2024
Psychosocial outcomes in a diverse sample of youth and their families who initiated continuous glucose monitoring within the first year of type 1 diabetes diagnosisAnanta Addala, Victor Ritter, Aika K Schneider-Utaka, et al.
Lancet Regional Health. Americas|March 14, 2025
Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in BrazilMarco Antonio Moreira Puga, Roberto Dias de Oliveira, Patricia Vieira da Silva, et al.
Pageof 2